DYN - Wall Street Estimates - Dyne Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 14.13

-4.33 %

$ 1.44 B

Market Cap

-3.95

P/E

Price Target Average

229.97%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

33.55%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Dyne Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for DYN of $46.6 , with forecasts ranging from a low of $40 to a high of $55 .

DYN Lowest Price Target Wall Street Target

40 USD 183.09%

DYN Average Price Target Wall Street Target

46.6 USD 229.97%

DYN Highest Price Target Wall Street Target

55 USD 289.24%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free